(Q49935482)

English

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.

scientific article published on 13 February 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol. (English)

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

1 reference

based on heuristic

lymphoplasmacytic lymphoma

1 reference

based on heuristic

1 reference

based on heuristic

Sattva S Neelapu

9

object named as

Sattva S Neelapu

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

author name string

Sheeba K Thomas

1

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Soung-Chul Cha

2

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

D Lynne Smith

3

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Kun Hwa Kim

4

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Sapna R Parshottam

5

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Sheetal Rao

6

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Michael Popescu

7

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Vincent Y Lee

8

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Larry W Kwak

10

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

language of work or name

0 references

publication date

13 February 2018

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

18

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

1

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

187

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

https://scigraph.springernature.com/pub.10.1186/s12885-018-4094-2

0 references

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Design and analysis of phase I clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Participation of the humoral immune system in the myeloma-specific transplantation resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Tumor Immunity Induced by Preimmunization With BALB/c Mouse Myeloma Protein2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

22 May 2018

Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

14 August 2018

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

14 August 2018

DNA immunization induces protective immunity against B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5812202

14 August 2018

Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genetic approach to idiotypic vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/29439670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12885-018-4094-2

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Dimensions Publication ID

0 references

release_5v56m2urvjgljgdcjakoxnvhhm

1 reference

https://api.fatcat.wiki/v0/release/5v56m2urvjgljgdcjakoxnvhhm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 February 2018

http://europepmc.org/abstract/PMC/5812202

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49935482&oldid=1839211576"